Form 4 for TMO Thermo Fisher Scientific
Accepted 2023-03-02 00:00:00 ET · period of report 2023-02-28 · accession 0001127602-23-008392 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-02 | 2023-02-28 | TMO | Williamson Stephen | SVP, CFO | F - Tax | $541.76 | -835 | 27.4K | -3% | -$452.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-28 | F | D | 835 | $541.76 | 27,393 | D | — | — |